A negative difference between cystatin C- and creatinine-based eGFR was associated with increased risk of dementia, cognitive decline, and adverse brain imaging outcomes.
Is a negative intraindividual difference in estimated glomerular filtration rates based on cystatin C and creatinine associated with an increased risk of dementia and cognitive decline?
A negative eGFRdiff may serve as a potential associative indicator for dementia and cognitive impairment, offering clinical value in risk assessment.
Absolute Event Rate: 0% vs 0%
A negative eGFRdiff was associated with an increased risk of dementia, adverse neuroimaging outcomes, and cognitive decline. These findings suggest that the eGFRdiff might be considered a potential associative indicator for dementia and cognitive impairment, suggesting potential clinical value in risk assessment and early intervention strategies.
Mao et al. (Fri,) reported a other. A negative difference between cystatin C- and creatinine-based eGFR was associated with increased risk of dementia, cognitive decline, and adverse brain imaging outcomes.